Identification and treatment of (sub)clinical transcatheter valve thrombosis
Sponsored by Daiichi Sankyo, Inc. and Pie Medical Imaging
Coronary Interventions
Other coronary interventions
Symposium
Drugs and Devices Synergy
Daiichi Sankyo, Inc.
Room 253
Discussants: Christian Hengstenberg, Rutger-Jan Nuis
Watch this session if you want
- To learn how to determine leaflet thickening and leaflet mobility by MSCT
- To get an update on antithrombotic treatment strategies of HALT/RLM
- To understand potential clinical implications of HALT and RLM (HAM)
Session objectives
Nicolas Van Mieghem
A practical guide to CT diagnosis of HALT/RLM
Hasan Jilhaihawi
Discussion and audience interaction
Why should we take HALT/RLM seriously?
Joelle Kefer
Discussion and audience interaction
How to approach HALT/HAM - Impact of pharmacotherapy
Christian Hengstenberg
Discussion and audience interaction
Session evaluation and key learnings
Nicolas Van Mieghem
